With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

Novo Nordisk ( NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its ...

The home shipments — which will be fulfilled by CenterWell Pharmacy — include Wegovy injections of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg.

Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23 percent ... CEO over steep prices for Ozempic and ...

Novo Nordisk is cutting the cost of its blockbuster ... This includes 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg dose strengths. The list price of the drug before insurance and certain rebates ...

Novo Nordisk Cuts Wegovy Prices ... Wegovy and Zepbound are part of a GLP-1 class of treatments that has shown unprecedented results for helping people shed weight by decreasing appetite and ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop ... Wegovy and Zepbound are part of a GLP-1 class of treatments that has shown unprecedented results for helping people shed weight ...

Danish group to sell Wegovy at reduced cost of $499 a month Drugmaker follows rival Eli Lilly with online platform launch Novo Nordisk A/S is following in rival Eli Lilly & Co. ’s footsteps by selling ...

Discover which tool is best for your business. Novo Nordisk reported 65.1 billion Danish krone (about $9.4 billion) in sales for obesity products in 2024, a 56% increase over sales in the prior year.

Type 1 diabetes occurs when the immune system attacks pancreatic beta cells. Type 2 diabetes happens when the body cannot use insulin effectively. The two types differ in symptoms, causes ...